, Tracking Stock Market Picks
Enter Symbol:
Ev3 Inc. (EVVV) [hlAlert]

down 18.35 %

Ev3 Inc. (EVVV) upgraded to Outperform with price target $20 by BMO Capital Markets

Posted on: Monday,  Apr 5, 2010  8:25 AM ET by BMO Capital Markets

BMO Capital Markets rated Outperform Ev3 Inc. (NASDAQ: EVVV) on 04/05/2010, when the stock price was $16.34. Since
then, Ev3 Inc. has lost 18.36% as of 07/12/2010's recent price of $13.34.
If you would have followed this BMO Capital Markets's recommendation on EVVV, you would have lost 18.35% of your investment in 98 days.

ev3 Inc. is a global medical device company focused on endovascular technologies for the minimally invasive treatment of vascular diseases and disorders.

The U.S. Equity Research team comprises over 25 analysts located in New York, Atlanta, Boston, Denver, Houston and Los Angeles. We cover more than 375 stocks and also provide equity strategy, quantitative analysis and portfolio management services to our clients. Our goal is to identify the best sectors to invest in, and the best stocks within those sectors, in order to help our clients maximize their portfolio returns. Our award-winning analysts provide research that is informative, perceptive and actionable.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/5/2010 8:25 AM Buy
16.34 20.00
as of 12/31/2010
1 Week   
1 Month   
3 Months   
1 YTD up  38.06 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/12/2009 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy